1 Min Read
Jan 18 (Reuters) - Zynerba Pharmaceuticals Inc
* Zynerba Pharmaceuticals Inc - estimates that as of December 31, 2016 cash and cash equivalents were approximately $31.0 million Source text - bit.ly/2jp373S Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.